Drug recall · May 29, 2024
Xelpros recall
Why: Failed Release Testing: Out of specification for particulate matter test.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., India., NDC 47335-317-90
- Lots / codes
Lot #: HAD3383A, Exp 8/31/2024
- Quantity
- 35,069 bottles
- Company
- Sun Pharmaceutical Industries Inc, Princeton, NJ
- Distribution
- TX, PA
- Initiated
- April 22, 2024 · Voluntary: Firm initiated
- Classified
- May 20, 2024
- Reported
- May 29, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Latanoprost
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.